News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Vertex Pharmaceuticals
NEWS
JOBS
IN THE PRESS
NEWS
Bio NC
Biotech Investors Bullish On Large Cap; Citi Adds Vertex Pharmaceuticals (MA), BioMarin Pharmaceutical Inc. and Tesaro, Inc. To Most Preferred
November 14, 2014
·
1 min read
FDA
Vertex Pharmaceuticals (MA) Surges As FDA Advisory Panel Approves Kalydeco’s Label Expansion
October 22, 2014
·
2 min read
Deals
Lung Biotech ProQR Therapeutics B.V. Files For A $75 Million IPO To Give Vertex Pharmaceuticals (MA) Some Competition
August 15, 2014
·
2 min read
Genetown
Vertex Pharmaceuticals (MA) To Stop Selling Once-Upon-A-Time Blockbuster Incivek, Shares Slip
August 12, 2014
·
1 min read
Genetown
Analyst Makes A Trip To Sweden, Returns Home Predicting Vertex Pharmaceuticals (MA) Cystic Fibrosis Drug Failure
June 17, 2014
·
1 min read
Biotech Bay
From Startup To Billion-Dollar Biotech: An Inside Look At Vertex Pharmaceuticals (MA)
February 28, 2014
·
1 min read
Job Trends
Vertex Pharmaceuticals (MA) Failure Shows Biotech is Not Immune to Big Pharma-Type Layoffs
November 4, 2013
·
1 min read
Business
Vertex Pharmaceuticals (MA)'s Matt Emmens on His Journey From Security Guard to CEO
January 27, 2010
·
1 min read
BioCapital
Pfizer Inc., Vertex Pharmaceuticals Incorporated Execs Are Victims of Facebook Faker; Forbes, Wall Street Journal Also Targeted
April 30, 2009
·
1 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Drug Development
Vertex Pharmaceuticals (MA) Announces Recent Progress and Upcoming Milestones in Research and Development Programs for Cystic Fibrosisv
October 17, 2013
·
1 min read
Policy
Vertex Pharmaceuticals (MA) Submits Supplemental New Drug Application (sNDA) to FDA for KALYDECO (ivacaftor) Monotherapy for People With Non-G551D Gating Mutations
September 30, 2013
·
1 min read
Business
Vertex Pharmaceuticals (MA) to Announce Third Quarter 2013 Financial Results on October 29
September 26, 2013
·
1 min read
Drug Development
Vertex Pharmaceuticals (MA) Shares Rocket as CF Drug Impresses in Phase 3 Study
July 30, 2013
·
7 min read
Business
Vertex Pharmaceuticals (MA) Reports Second Quarter 2013 Financial Results and Reviews Recent Progress and Upcoming Milestones in Clinical Development Programs
July 30, 2013
·
1 min read
Drug Development
Vertex Pharmaceuticals (MA) Tanks as FDA Puts Hold on Hep C Trial
July 26, 2013
·
1 min read
FDA
TGA of Australia Approves Vertex Pharmaceuticals (MA)'s KALYDECO for Cystic Fbrosis
July 10, 2013
·
10 min read
Business
Vertex Pharmaceuticals (MA) to Announce Second Quarter 2013 Financial Results on July 29
June 28, 2013
·
1 min read
Genetown
Vertex Pharmaceuticals (MA) Completes Redemption of Convertible Senior Subordinated Notes
June 18, 2013
·
1 min read
Drug Development
These Mutated Cystic Fibrosis Cells are Worth Billions to Vertex Pharmaceuticals (MA)
June 14, 2013
·
1 min read
